Collplant Biotechnologies Ltd recorded one insider transaction over the past ninety days. A ten percent stockholder, Lilian S. Loewenbaum, initiated a proposed sale valued at 58,934 dollars. This activity follows a recent earnings report where the company outperformed expectations by 21.25 percent, amid a 22.6 percent stock price increase during the same period.